Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...

Electrocardiogram

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Correlation between ECG and Cardiac Cycle

Correlation between ECG and Cardiac Cycle

The electrical signals recorded on an electrocardiogram (ECG) occur before the mechanical processes of contraction and relaxation during the cardiac cycle.
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Cardiovascular Risks Associated with the use of Performance-Enhancing Stimulants].

Kardiologiia·2021

Same author

[Syncope in Young Elite Athletes].

Kardiologiia·2017

Same author

[Microvolt T-Wave Alternans in Adolescent Elite Athletes].

Kardiologiia·2017

Same author

[To the Centennial of Norman Holter (19141983)].

Kardiologiia·2017

Same author

[Microvolt T-wave alternans in adolescent elite athletes].

Kardiologiia·2015

Same author

[To the centennial of Norman Holter (1914-1983)].

Kardiologiia·2015

Search research articles

Related Experiment Video

Updated: Dec 1, 2025

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

[QT Interval in Patients With COVID-19].

V N Komoliatova¹, L M Makarov¹

¹Center for syncope and cardiac arrhythmias in children and adolescents of the FMBA of Russia. FGBUZ Central Children's Clinical Hospital FMBA of Russia. Department of Pediatrics named after G.N. Speransky RMANPO Ministry of Health of the Russian Federation.

|November 6, 2020

Summary

This summary is machine-generated.

The COVID-19 pandemic poses public health risks. Certain treatments, like azithromycin and hydroxychloroquine, may increase cardiac risks, necessitating careful patient management strategies.

More Related Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

In Vivo Surface Electrocardiography for Adult Zebrafish

In Vivo Surface Electrocardiography for Adult Zebrafish

Published on: August 1, 2019

Related Experiment Videos

Last Updated: Dec 1, 2025

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

In Vivo Surface Electrocardiography for Adult Zebrafish

In Vivo Surface Electrocardiography for Adult Zebrafish

Published on: August 1, 2019

Area of Science:

Cardiology
Infectious Diseases
Pharmacology

Background:

The emergence of SARS-CoV-2 has led to the COVID-19 pandemic.
COVID-19 presents a significant global public health challenge.
Standard treatments for COVID-19 may carry cardiac risks.

Purpose of the Study:

To review the potential cardiac risks associated with COVID-19 pharmacotherapy.
To provide recommendations for managing patients during the COVID-19 pandemic.
To highlight the importance of electrocardiogram monitoring in patients receiving specific COVID-19 treatments.

Main Methods:

Literature review of existing studies on COVID-19 treatments.
Analysis of drug information regarding known cardiac side effects.
Synthesis of clinical recommendations for patient care.

Main Results:

Azithromycin and hydroxychloroquine can prolong the QT interval.
QT interval prolongation increases the risk of Torsades de Pointes (a type of pirouette tachycardia).
This arrhythmia can lead to sudden cardiac death.

Conclusions:

Careful consideration of cardiac risks is essential when prescribing COVID-19 treatments.
Patient management should include monitoring for potential drug-induced cardiac events.
Proactive strategies are needed to mitigate adverse cardiovascular outcomes in COVID-19 patients.